1. Home
  2. MDWD vs FSFG Comparison

MDWD vs FSFG Comparison

Compare MDWD & FSFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • FSFG
  • Stock Information
  • Founded
  • MDWD 2000
  • FSFG 2008
  • Country
  • MDWD Israel
  • FSFG United States
  • Employees
  • MDWD N/A
  • FSFG N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • FSFG Savings Institutions
  • Sector
  • MDWD Health Care
  • FSFG Finance
  • Exchange
  • MDWD Nasdaq
  • FSFG Nasdaq
  • Market Cap
  • MDWD 208.2M
  • FSFG 165.5M
  • IPO Year
  • MDWD 2014
  • FSFG 2008
  • Fundamental
  • Price
  • MDWD $19.34
  • FSFG $26.05
  • Analyst Decision
  • MDWD Strong Buy
  • FSFG Strong Buy
  • Analyst Count
  • MDWD 2
  • FSFG 3
  • Target Price
  • MDWD $35.00
  • FSFG $31.50
  • AVG Volume (30 Days)
  • MDWD 48.9K
  • FSFG 55.1K
  • Earning Date
  • MDWD 08-13-2025
  • FSFG 07-24-2025
  • Dividend Yield
  • MDWD N/A
  • FSFG 2.46%
  • EPS Growth
  • MDWD N/A
  • FSFG 159.10
  • EPS
  • MDWD N/A
  • FSFG 2.81
  • Revenue
  • MDWD $19,213,000.00
  • FSFG $75,839,000.00
  • Revenue This Year
  • MDWD $20.80
  • FSFG $0.06
  • Revenue Next Year
  • MDWD $26.92
  • FSFG $8.60
  • P/E Ratio
  • MDWD N/A
  • FSFG $9.26
  • Revenue Growth
  • MDWD N/A
  • FSFG N/A
  • 52 Week Low
  • MDWD $14.14
  • FSFG $17.75
  • 52 Week High
  • MDWD $24.00
  • FSFG $30.94
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 40.24
  • FSFG 55.34
  • Support Level
  • MDWD $18.97
  • FSFG $23.49
  • Resistance Level
  • MDWD $19.87
  • FSFG $26.28
  • Average True Range (ATR)
  • MDWD 0.57
  • FSFG 0.77
  • MACD
  • MDWD -0.17
  • FSFG 0.17
  • Stochastic Oscillator
  • MDWD 25.31
  • FSFG 81.00

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About FSFG First Savings Financial Group Inc.

First Savings Financial Group Inc provides various banking services to individuals and business customers in southern Indiana. The bank accepts deposits from the general public & uses those funds, along with other borrowings, mainly to originate a residential mortgage, commercial mortgage, construction, commercial business, & consumer loans, and to a lesser extent, to invest in mortgage-backed securities and other debt securities. The company conducts lending and deposit activities mainly with individuals and small businesses in its market area. The bank operates in two segments: core banking, which accounts for the majority of revenue, and SBA lending.

Share on Social Networks: